BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 19753835)

  • 1. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
    Rodríguez G; Pinto R; López F; Gómez Y
    Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythema leprosum--after treatment of Lepromatous Leprosy.
    Eickelmann M; Steinhoff M; Metze D; Tomimori-Yamashita J; Sunderkötter C
    J Dtsch Dermatol Ges; 2010 Jun; 8(6):450-3. PubMed ID: 19922466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necrotic erythema nodosum leprosum with oral mucosal involvement.
    Swain JP; Soud A; Agarwal SK
    Indian J Lepr; 2008; 80(2):175-8. PubMed ID: 19425513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-abdominal, crystal-storing histiocytosis due to clofazimine in a patient with lepromatous leprosy and concurrent carcinoma of the colon.
    Pais AV; Pereira S; Garg I; Stephen J; Antony M; Inchara YK
    Lepr Rev; 2004 Jun; 75(2):171-6. PubMed ID: 15282969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Leprosy and the testis].
    Rodríguez G; Abaúnza MC; Vargas EJ; López F
    Biomedica; 2012; 32(1):13-22. PubMed ID: 23235783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for erythema nodosum leprosum.
    Manandhar R; LeMaster JW; Roche PW
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare variant of erythema nodosum leprosum: a case report.
    Dave S; Thappa DM; Nori AV; Jayanthi S
    Dermatol Online J; 2003 Dec; 9(5):11. PubMed ID: 14996384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
    Goulart IM; Reis AC; De Rezende TM; Borges AS; Ferreira MS; Nishioka SA
    Lepr Rev; 2005 Jun; 76(2):167-9. PubMed ID: 16038251
    [No Abstract]   [Full Text] [Related]  

  • 11. [Patient with Hansen disease and lepromatous reaction with predominant neural involvement].
    Gálvez J; López-Domínguez JM; Navarro A; Creagh R; Casado JL; Chinchón Lara I
    Neurologia; 1998 Jan; 13(1):41-4. PubMed ID: 9522583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythema nodosum leprosum necroticans in a child--an unusual manifestation.
    Pandhi D; Mehta S; Agrawal S; Singal A
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):122-6. PubMed ID: 16830655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal ocular survey of 202 Filipino patients with multi-bacillary (MB) leprosy treated with 2 year WHO-multiple drug therapy.
    Ravanes JM; Cellona RV; Balagon M; Abalos RM; Walsh GP; Walsh DS
    Southeast Asian J Trop Med Public Health; 2011 Mar; 42(2):323-30. PubMed ID: 21710853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clofazimine induced enteropathy--a case highlighting the importance of drug induced disease in differential diagnosis.
    Mathew BS; Pulimood AB; Prasanna CG; Ramakrishna BS; Chandy SJ
    Trop Gastroenterol; 2006; 27(2):87-8. PubMed ID: 17089619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polyarthritis and papular eruption revealing leprosy].
    Meyer M; Ingen-Housz-Oro S; Ighilahriz O; Wendling J; Gaulier A; Levy-Weil F; Sigal-Grinberg M; Flageul B
    Rev Med Interne; 2008 Mar; 29(3):242-5. PubMed ID: 17976874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
    Balagon M; Saunderson PR; Gelber RH
    Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histoid leprosy with erythema nodosum leprosum].
    Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
    Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clofazimine: new products. Major antileprous drug.
    Prescrire Int; 1999 Apr; 8(40):44-6. PubMed ID: 10848059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.